Skip to main content
OpenTrials

Clinical trial condition

Adenocarcinoma

Explore clinical trials studying Adenocarcinoma. Study availability and eligibility vary by location and protocol.

5,062 public trials 1,186 recruiting studies
Refine in advanced search Browse all conditions

Adenocarcinoma trial results

Active, not recruiting

A Study of Cabozantinib and Nivolumab With Radiation Therapy for People With Renal Cell Carcinoma That Has Spread to the Brain

NCT06132945

Conditions
Adenocarcinoma, Brain Diseases, Brain Metastases, +21 more
Locations
  • Memorial Sloan Kettering Basking Ridge (All Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (All Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (All Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Cancer Suffolk - Commack (All Protocol Activities) Commack, New York, United States
View Trial Details
Active, not recruiting

A Study of Cobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With Cancer

NCT06521567

Conditions
Adenocarcinoma, Astrocytoma, Brain Diseases, +56 more
Locations
  • GSK Investigational Site Los Angeles, California, United States
  • GSK Investigational Site Iowa City, Iowa, United States
  • GSK Investigational Site Hackensack, New Jersey, United States
  • GSK Investigational Site Cincinnati, Ohio, United States
View all 20 locations
View Trial Details
Active, not recruiting

A Study of Pembrolizumab (MK-3475) in Combination With Belzutifan (MK-6482) and Lenvatinib (MK-7902), or Pembrolizumab/Quavonlimab (MK-1308A) in Combination With Lenvatinib, vs Pembrolizumab and Lenvatinib, for Treatment of Advanced Clear Cell Renal Cell Carcinoma (MK-6482-012)-China Extension Study

NCT05899049

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations
  • Beijing Cancer hospital-Renal carcinoma and melanoma ( Site 6000) Beijing, Beijing Municipality, China
  • Chongqing University Cancer Hospital ( Site 6009) Chongqing, Chongqing Municipality, China
  • SUN YAT-SEN UNIVERSITY CANCER CENTRE ( Site 6003) Guangzhou, Guangdong, China
  • The First Affiliated Hospital of Guangzhou Medical University-Urology ( Site 6036) Guangzhou, Guangdong, China
View all 17 locations
View Trial Details
Active, not recruiting

NBTXR3 Activated by Radiotherapy for Patients With Advanced Cancers Treated With An Anti-PD-1 Therapy

NCT03589339

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +47 more
Locations
  • University of California San Francisco San Francisco, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Emory University Atlanta, Georgia, United States
  • University of Chicago Medical Center Chicago, Illinois, United States
View all 13 locations
View Trial Details
Active, not recruiting

ALTUS: Performance of a Multi- Target Hepatocellular Carcinoma (HCC) Test in Subjects With Increased Risk

NCT05064553

Conditions
Adenocarcinoma, Blood-Borne Infections, Carcinoma, +24 more
Locations
  • Arizona Health Research Chandler, Arizona, United States
  • Arizona Digestive Health - Sun City Sun City, Arizona, United States
  • Franco Felizarta, MD Bakersfield, California, United States
  • Gastroenterology & Liver Institute Escondido, California, United States
View all 76 locations
View Trial Details

Related conditions